Bgnd_Elastrin.png

Meet the team. We are bringing the future to you. 

The Elastrin team sources of 100+ years converting science into applicable technologies.

Our Milestones – so far.

2021.png

Elastrin Therapeutics closes its Seed Funding Round with Kizoo Technology Capital

2017.png

Patent Application published for “Delivery Agents Targeted to Degraded Elastic Fibers”

2015.png

Publication on targeted drug delivery to emphysematous lungs in Pulmonary Pharmacology & Therapeutics.

Patent application published for “Delivery Agents for Targeted Treatment of Elastin Degradation”

2014.png

Publication on targeted EDTA chelation therapy in Journal of Controlled Release. Read it here.

NIH Director highlights the achievements and potential of the findings.

2012.png

Patent awarded for “Elastin stabilization of connective tissue”

2003.png

NIH Grant awarded for project “GAGs: Function &Fixation in Bioprosthetic Heart Valves” which supported Vyavahare’s research with over $5.8 million until 2011.

2000.png

NIH Grant awarded for project “Calcification of Elastin -- Mechanisms and Prevention” which supported Vyavahare’s work in this field with over $2 million through 2008.